Evaluation of the effect of portal vein embolization on liver function by 99mTc-galactosyl human serum albumin scintigraphy

Journal of Surgical Research

Volumn 107, Issue 1, 2002, Pages 113-118

  Kubo, Shoji ^a   Shiomi, Susumu ^a   Tanaka, Hiromu ^a   Shuto, Taichi ^a   Takemura, Shigekazu ^a   Mikami, Shinichi ^a   Uenishi, Takahiro ^a   Nishino, Yoshihiro ^a   Hirohashi, Kazuhiro ^a   Kawamura, Etsushi ^a   Kinoshita, Hiroaki ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

99mTc GSA scintigraphy; Chronic hepatitis; Hepatocellular carcinoma; Liver cirrhosis; Liver resection; Percutaneous transhepatic portal vein embolization

Indexed keywords

HUMAN SERUM ALBUMIN TC 99M; RECEPTOR;

ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; CALCULATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; LIVER FUNCTION; LIVER RESECTION; LOBECTOMY; MALE; PORTAL HYPERTENSION; PORTAL VEIN; POSTOPERATIVE PERIOD; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SCINTIGRAPHY; TREATMENT OUTCOME;

EID: 0036401209     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.2002.6503     Document Type: Article

References (31)

1. Liver Cancer Study Group of Japan. Primary liver cancer in Japan: Clinicopathologic features and results of surgical treatment. Ann. Surg. 211: 277, 1990.
2. Kinoshita, H., Sakai, K., Hirohashi, K., Igawa, S., Yamasaki, O., and Kubo, S. Preoperative portal vein embolization for hepatocellular carcinoma. World J. Surg. 10: 803, 1986.
3. Kinoshita, H., Hirohashi, K., and Kubo, S. Preoperative portal vein embolization for hepatocellular carcinoma. In T. Tobe, H. Kameda, M. Okudaira, M. Ohto, Y. Endo, M. Mito, E. Okamoto, K. Tanikawa, and M. Kojiro (Eds.), Primary Liver Cancer in Japan. Berlin: Springer-Verlag, 1991. Pp. 282-290.
4. Kubo, S., Kinoshita, H., Hirohashi, K., Tanaka, H., Tsukamoto, T., Shuto, T., Morimoto, Y., Kanazawa, A., Mikami, S., and Sakata, C. Efficacy of preoperative portal vein embolization prior to a major hepatectomy for patients with impaired liver function: A retrospective study. J. Hep. Bil. Pancr. Surg. 4: 359, 1997.
5. Tanaka, H., Hirohashi, K., Kubo, S., Shuto, T., Higaki, I., and Kinoshita, H. Preoperative portal vein embolizaation improves prognosis after right hepatectomy for hepatocellular carcinoma in patients with impaired hepaic function. Br. J. Surg. 87: 879, 2000.
6. Makuuchi, M., Thai, B. L., Takayasu, K., Takayama, T., Kosuge, T., Gunven, P., Yamazaki, S., Hasegawa, H., and Ozaki, H. Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: A preliminary report. Surgery 107: 521, 1990.
7. Nagino, M., Nimura, Y., Kamiya, J., Kondo, S., Uesaka, K., Kin, Y., Kutsuna, Y., Hayakawa, N., and Yamamoto, H. Right or left trisegment portal vein embolization before hepatic trisegmentectomy for hilar bile duct carcinoma. Surgery 117: 677, 1995.
8. Miyanaga, S., Makuuchi, M., Kawasaki, S., Hayashi, K., Harada, H., Kitamura, H., and Seki, H. Outcome of major hepatectomy with pancreatoduodenectomy for advanced biliary malignancies. World J. Surg. 20: 77, 1996.
9. Abdalla, E. K., Hicks, M. E., and Vauthey, J. N. Portal vein embolization: Rationale, technique and future prospects. Br. J. Surg. 88: 165, 2001.
10. Kubo, S., Matsui-Yuasa, I., Otani, S., Morisawa, S., Kinoshita, H., and Sakai, K. Effect of portal branch ligation on polyamine metabolism in rat liver. Life Sci. 38: 1835, 1986.
11. Kinoshita, H., Sakai, K., Iwasa, R., Hirohashi, K., Kubo, S., Fujio, N., and Lee, K. C. Results of preoperative portal vein embolization for hepatocellular carcinoma. Osaka City Med. J. 34: 115, 1988.
12. Lee, K. C., Kinoshita, H., Hirohashi, K., Kubo, S., and Iwasa, R. Extension of surgical indications for hepatocellular carcinoma by portal vein embolization. World J. Surg. 17: 109, 1993.
13. Tanaka, H., Kinoshita, H., Hirohashi, K., Kubo, S., and Lee, K. C. Increased safety by two-stage hepatectomy with preoperative portal vein embolization in rats. J. Surg. Res. 57: 687, 1994.
14. Vera, D. R., Krohn, K. A., Stadalnik, R. C., and Scheibe, P. O. Tc-99m-galactosyl-neoglycoalbumin: In vivo characterization of receptor-mediated binding to hepatocytes. Radiology 151: 191, 1984.
15. Vera, D. R., Stadalnik, R. C., Trudeau, W. L., Scheibe, P. O., and Krohn, K. A. Measurement of receptor concentration and forward-binding rate constant via radiopharmacokinetic modeling of technetium-99m-galaactosyl-neoglycoalbumin. J. Nucl. Med. 32: 1169, 1991.
16. Kudo, M., Vera, D. R., Trudeau, W. L., and Stadalnik, R. C. Validation of in vivo receptor measurements via in vitro radio-assay: Technetium-99m-galactosyl-neoglycoalbumin as prototype model. J. Nucl. Med. 32: 1177, 1991.
17. Kudo, M., Vera, D. R., Stadalnik, R. C., Trudeau, W. L., Ikekubo, K., and Todo, A. In vivo estimates of hepatic binding protein concentration: Correlation with classical indicators of hepatic functional reserve. Am. J. Gastroenterol. 85: 1142, 1990.
18. Pimstone, N. R., Stadalnik, R. C., Vera, D. R., Hutak, D. P., and Trudeau, W. L. Evaluation of hepatocellular function by way of receptor-mediated uptake of a technetium-99m-labeled asialoglycoprotein analog. Hepatology 20: 917, 1994.
19. Shiomi, S., Kuroki, T., Kuriyama, M., Takeda, T., Nishiguchi, S., Nakajima, S., Tanaka, T., and Ochi, H. Evaluation of fulminant hepatic failure by scintigraphy with technetium-99m-GSA. J. Nucl. Med. 38: 79, 1997
20. 99mTc-Galactosyl-human serum albumin for prognosis of cirrhosis of the liver. J. Nucl. Med. 40: 1652, 1999
21. Yumoto, Y., Umeda, M., Ohshima, K., Ogawa, H., Kurokawa, T., Kajitani, M., Yumoto, E., Hanafusa, T., Tsuboi, H., Higashi, T., Mitani, T., and Tsuji, T. Estimation of remnant liver function before hepatectomy by means of technetium-99m-diethylenetriamine pentaacetic acid galactosyl human albumin. Cancer Chemother. Pharmacol. 33(Suppl.): S1, 1994.
22. Kwon, A. H., Ha-Kawa, S. K., Uetsuji, S., Kamiyama, Y., and Tanaka, Y. Use of technetium 99m diethylenetriamine-pentaacetic acid-galactosyl-human serum albumin liver scintigraphy in the evaluation of preoperative and postoperative hepatic functional reserve for hepatectomy. Surgery 117: 429, 1995.
23. 99mTc-DTPA-galactosyl-human serum albumin dynamic SPECT. J. Nucl. Med. 40: 1644, 1999.
24. Kubota, K., Makuuchi, M., Kusaka, K., Kobayashi, T., Miki, K., Hasegawa, K., Harihara, Y., and Takayama, T. Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resectional surgery for hepatic tumors. Hepatology 26: 1176, 1997
25. Desmet, V. J., Gerber, M., Hoofnagle, J. H., Manns, M., and Scheuer, P. J. Classification of chronic hepatitis: Diagnosis, grading and staging. Hepatology 19: 1513, 1994
26. Fujio, N., Sakai, K., Kinoshita, H., Hirohashi, K., Kubo, S., Iwasa, R., and Lee, K. C. Results of treatment of patients with hepatocellular carcinoma with severe cirrhosis of the liver. World J. Surg. 13: 211, 1989.
27. Uesaka, K., Nimura, Y., and Nagino, M. Changes in hepatic lobar function after right portal vein embolization: An appraisal by biliary indocyanine green excretion. Ann. Surg. 233: 77, 1996.
28. Nishiguchi, S., Shiomi, S., Sasaki, N., Iwata, Y., Mikami, S., Tanaka, H., Kubo, S., and Ochi, H. Course before and after percutaneous transhepatic portal vein embolization of a patient with cholangiocarcinoma monitored by scintigraphy with Tc-99m galactosyl human serum albumin. Ann. Nucl. Med. 14: 231, 2000.
29. Ikeda, K., Kinoshita, H., Hirohashi, K., Kubo, S., and Kaneda, K. The ultrastructure, kinetics and intralobular distribution of apoptotic hepatocytes after portal branch ligation with special reference to their relationship to necrotic hepatocytes. Arch. Histol. Cytol. 58: 171, 1995.
30. Bruix, J., Castells, A., Bosch, J., Feu, F., Fuster, J., Garcia-Pagan, J. C., Visa, J., Bru, C., and Rodes, J. Surgical resection of hepatocellular carcinoma in cirrhotic patients: Prognostic value of preoperative portal pressure. Gastroenterology 111: 1018, 1996.
31. 99mTc-GSA SPECT and their usefulness in prognostic estimation after hepatectomy. J. Nucl. Med. 41: 421, 2000.